WaveMan · Form 4
5AM Partners VII, LLC insider trades
> Search tickers & screens ⌘K
LIVE

5AM Partners VII, LLC insider trades

5AM Partners VII, LLC has filed 3 Form 4s with the SEC that we hold, all for Skye Bioscience, Inc. (SKYE), as 10% owner. Across all of them we count 0 purchases worth $0 and 15 sales worth $444.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 15 sales ($444.6K). The largest single trade was a sale of 114,851 shares of Skye Bioscience, Inc. worth $184.9K, dated 2026-09-23. Of 15 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-08-20 and the latest 2026-09-24.

Skye Bioscience, Inc. (SKYE)

10% owner · 3 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-08-18S, sale reported on Form 445,090$17.1K2026-08-20
2026-08-18S, sale reported on Form 41,830$6952026-08-20
2026-08-18S, sale reported on Form 4253,080$96.2K2026-08-20
2026-08-19S, sale reported on Form 410,255$3.6K2026-08-20
2026-08-19S, sale reported on Form 4409$1432026-08-20
2026-08-19S, sale reported on Form 457,476$20.1K2026-08-20
2026-08-20S, sale reported on Form 41,159$3712026-08-20
2026-08-20S, sale reported on Form 446$152026-08-20
2026-08-20S, sale reported on Form 46,495$2.1K2026-08-20
2026-09-16S, sale reported on Form 432,607$62.3K2026-09-18
2026-09-16S, sale reported on Form 41,285$2.5K2026-09-18
2026-09-22S, sale reported on Form 427,612$45.6K2026-09-24
2026-09-22S, sale reported on Form 41,088$1.8K2026-09-24
2026-09-23S, sale reported on Form 4114,851$184.9K2026-09-24
2026-09-23S, sale reported on Form 44,528$7.3K2026-09-24
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1873545) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms